NCT04882319View on ClinicalTrials.gov

Irritation and Sensitization Study of HP-5000 Topical System

PHASE1CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 3, 2021

Primary Completion Date

March 8, 2022

Study Completion Date

March 11, 2022

Conditions
Osteoarthritis of the Knee
Interventions
DRUG

HP-5000 Topical Patch

HP-5000, placebo and saline will be administered simultaneously

DRUG

HP-5000 Placebo Patch

HP-5000, placebo and saline will be administered simultaneously

DRUG

Saline Patch

HP-5000, placebo and saline will be administered simultaneously

Trial Locations (1)

07410

TKL Research, Fair Lawn

Sponsors
All Listed Sponsors
lead

Noven Pharmaceuticals, Inc.

INDUSTRY